Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11762939rdf:typepubmed:Citationlld:pubmed
pubmed-article:11762939lifeskim:mentionsumls-concept:C0029456lld:lifeskim
pubmed-article:11762939lifeskim:mentionsumls-concept:C0029418lld:lifeskim
pubmed-article:11762939lifeskim:mentionsumls-concept:C0029433lld:lifeskim
pubmed-article:11762939lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:11762939lifeskim:mentionsumls-concept:C1533698lld:lifeskim
pubmed-article:11762939lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:11762939lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:11762939lifeskim:mentionsumls-concept:C0678227lld:lifeskim
pubmed-article:11762939lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:11762939lifeskim:mentionsumls-concept:C1880177lld:lifeskim
pubmed-article:11762939pubmed:issue12lld:pubmed
pubmed-article:11762939pubmed:dateCreated2001-12-13lld:pubmed
pubmed-article:11762939pubmed:abstractTextOsteoporosis is a major clinical problem in chronic inflammatory diseases such as rheumatoid arthritis. The mechanism of bone loss in this condition remains unclear, but previous studies have indicated that depressed bone formation plays a causal role. Since cytokine-induced nitric oxide (NO) production has been shown to inhibit osteoblast growth and differentiation in vitro, this study was undertaken to investigate the role of the inducible NO synthase (iNOS) pathway in the pathogenesis of inflammation-mediated osteoporosis (IMO) by studying mice with targeted inactivation of the iNOS gene (iNOS knockout [iNOS KO] mice).lld:pubmed
pubmed-article:11762939pubmed:languageenglld:pubmed
pubmed-article:11762939pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11762939pubmed:citationSubsetAIMlld:pubmed
pubmed-article:11762939pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11762939pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11762939pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11762939pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11762939pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11762939pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11762939pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11762939pubmed:statusMEDLINElld:pubmed
pubmed-article:11762939pubmed:monthDeclld:pubmed
pubmed-article:11762939pubmed:issn0004-3591lld:pubmed
pubmed-article:11762939pubmed:authorpubmed-author:ReidD MDMlld:pubmed
pubmed-article:11762939pubmed:authorpubmed-author:LiewF YFYlld:pubmed
pubmed-article:11762939pubmed:authorpubmed-author:RalstonS HSHlld:pubmed
pubmed-article:11762939pubmed:authorpubmed-author:CaoJ YJYlld:pubmed
pubmed-article:11762939pubmed:authorpubmed-author:ArmourK JKJlld:pubmed
pubmed-article:11762939pubmed:authorpubmed-author:van't HofR...lld:pubmed
pubmed-article:11762939pubmed:authorpubmed-author:ArmourK EKElld:pubmed
pubmed-article:11762939pubmed:issnTypePrintlld:pubmed
pubmed-article:11762939pubmed:volume44lld:pubmed
pubmed-article:11762939pubmed:ownerNLMlld:pubmed
pubmed-article:11762939pubmed:authorsCompleteYlld:pubmed
pubmed-article:11762939pubmed:pagination2790-6lld:pubmed
pubmed-article:11762939pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11762939pubmed:meshHeadingpubmed-meshheading:11762939...lld:pubmed
pubmed-article:11762939pubmed:meshHeadingpubmed-meshheading:11762939...lld:pubmed
pubmed-article:11762939pubmed:meshHeadingpubmed-meshheading:11762939...lld:pubmed
pubmed-article:11762939pubmed:meshHeadingpubmed-meshheading:11762939...lld:pubmed
pubmed-article:11762939pubmed:meshHeadingpubmed-meshheading:11762939...lld:pubmed
pubmed-article:11762939pubmed:meshHeadingpubmed-meshheading:11762939...lld:pubmed
pubmed-article:11762939pubmed:meshHeadingpubmed-meshheading:11762939...lld:pubmed
pubmed-article:11762939pubmed:meshHeadingpubmed-meshheading:11762939...lld:pubmed
pubmed-article:11762939pubmed:meshHeadingpubmed-meshheading:11762939...lld:pubmed
pubmed-article:11762939pubmed:meshHeadingpubmed-meshheading:11762939...lld:pubmed
pubmed-article:11762939pubmed:meshHeadingpubmed-meshheading:11762939...lld:pubmed
pubmed-article:11762939pubmed:meshHeadingpubmed-meshheading:11762939...lld:pubmed
pubmed-article:11762939pubmed:meshHeadingpubmed-meshheading:11762939...lld:pubmed
pubmed-article:11762939pubmed:meshHeadingpubmed-meshheading:11762939...lld:pubmed
pubmed-article:11762939pubmed:meshHeadingpubmed-meshheading:11762939...lld:pubmed
pubmed-article:11762939pubmed:meshHeadingpubmed-meshheading:11762939...lld:pubmed
pubmed-article:11762939pubmed:meshHeadingpubmed-meshheading:11762939...lld:pubmed
pubmed-article:11762939pubmed:meshHeadingpubmed-meshheading:11762939...lld:pubmed
pubmed-article:11762939pubmed:year2001lld:pubmed
pubmed-article:11762939pubmed:articleTitleActivation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis.lld:pubmed
pubmed-article:11762939pubmed:affiliationUniversity of Aberdeen Medical School, UK.lld:pubmed
pubmed-article:11762939pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11762939pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11762939lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11762939lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11762939lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11762939lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11762939lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11762939lld:pubmed